162 related articles for article (PubMed ID: 16177872)
1. Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections?
Kopp R; Diebold J; Dreier I; Cramer C; Glas J; Baretton G; Jauch KW
Surg Endosc; 2005 Nov; 19(11):1507-12. PubMed ID: 16177872
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
Wolf HK; Stöber C; Hohenfellner R; Leissner J
Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
[TBL] [Abstract][Full Text] [Related]
4. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of biological apoptosis factors in gastric cancer.
Sezer C; Yildirim M; Yildiz M; Sezgin A; Donem Dilli U; Goktas S; Bulbuller N
J BUON; 2013; 18(1):138-46. PubMed ID: 23613399
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study.
Sirvent JJ; Aguilar MC; Olona M; Pelegrí A; Blázquez S; Gutiérrez C
Histol Histopathol; 2004 Jul; 19(3):759-70. PubMed ID: 15168338
[TBL] [Abstract][Full Text] [Related]
7. Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma.
Maeta Y; Tsujitani S; Matsumoto S; Yamaguchi K; Tatebe S; Kondo A; Ikeguchi M; Kaibara N
Gastric Cancer; 2004; 7(2):78-84. PubMed ID: 15224193
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosis (cannibalism) of apoptotic neutrophils by tumor cells in gastric micropapillary carcinomas.
Barresi V; Branca G; Ieni A; Rigoli L; Tuccari G; Caruso RA
World J Gastroenterol; 2015 May; 21(18):5548-54. PubMed ID: 25987778
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of bcl-2 expression in gastric cancer.
Müller W; Schneiders A; Hommel G; Gabbert HE
Anticancer Res; 1998; 18(6B):4699-704. PubMed ID: 9891543
[TBL] [Abstract][Full Text] [Related]
10. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Bcl-2 and p53 expression in gastric cancer.
Lee HK; Lee HS; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Int J Colorectal Dis; 2003 Nov; 18(6):518-25. PubMed ID: 12811476
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and Bbcl-2 expression in gastric carcinomas: correlation withclinicopathological variables, p53 expression, cell proliferation and prognosis.
Aizawa K; Ueki K; Suzuki S; Yabusaki H; Kanda T; Nishimaki T; Suzuki T; Hatakeyama K
Int J Oncol; 1999 Jan; 14(1):85-91. PubMed ID: 9863013
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma.
Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y
Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457
[TBL] [Abstract][Full Text] [Related]
15. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
[TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of apoptosis inducers/inhibitors in stomach carcinoma with/without adjuvant intraoperative radiotherapy (IORT)].
Kopp R; Krämling HJ; Cramer C; Diebold J; Baretton G; Schildberg FW
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1360-2. PubMed ID: 9931882
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan.
Tokunaga M; Ito S; Yoshikawa T; Nunobe S; Fukagawa T; Misawa K; Cho H; Katai H; Sano T; Terashima M
Br J Surg; 2017 Jun; 104(7):885-890. PubMed ID: 28240355
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in prostate cancer.
Stattin P
Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]